3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 3
1
Status
Recruiting
3
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Genitourinary
3
Conditions
Prostatic Neoplasms
8
Urinary Bladder Neoplasms
3
Neoplasms
2
Urothelial Bladder Cancer
1
Urologic Neoplasms
1
Urinary Bladder Diseases
1
Recurrence
1
Driving Under the Influence
1
Disease Progression
1
Carcinoma, Hepatocellular
1
Interventions
Gemcitabine
56
pembrolizumab
50
Cisplatin
43
Magnetic Resonance Spectroscopy
27
enfortumab vedotin
22
Specimen Handling
22
Nivolumab
22
Cystectomy
18
durvalumab
16
Carboplatin
16
avelumab
15
Mitomycin
14
atezolizumab
13
Docetaxel
13
Cystoscopy
12
Fluorouracil
11
Radiation
9
Transurethral Resection of Bladder
8
Radiotherapy
8
Ipilimumab
8
sacituzumab govitecan
7
Standard of Care
7
Radiosurgery
7
Paclitaxel
7
Immunoglobulin G
7
Disulfides
7
erdafitinib
6
cemiplimab
6
Surveys and Questionnaires
6
Surgical Procedures, Operative
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Urinary Bladder Neoplasms
×
Multiparametric Magnetic Resonance Imaging
×
1 year
×
Clear all
NCT05779631
2026-01-08
BladParadigm
Radboud University Medical Center
Phase NA
Recruiting
360 enrolled
NCT04442724
2025-08-14
FMBRT
Cedars-Sinai Medical Center
Phase NA
Recruiting
60 enrolled
NCT07067749
2025-07-24
TEMPO-MIBC
University of Rome Tor Vergata
Phase 3
Recruiting
92 enrolled